PCSK9 inhibitor treatment and outcomes in patients with atherosclerotic cardiovascular disease but without prior ischaemic events: an observational study. [PDF]
Bhatt DL +9 more
europepmc +1 more source
Mode of access: Internet.Official publication of the Purchasing Agents' Association of Northern California ...
Purchasing Agents' Association of Northern California.
core
Little Evidence of Atherosclerosis in a Middle-aged Japanese Woman with Familial Hypercholesterolemia Carrying PCSK9 (p.Glu32Lys) and ABCG8 (p.Ile419Asn) Variants despite Elevated Lipoprotein (a) Levels. [PDF]
Aono K +4 more
europepmc +1 more source
Discovery of Cetaben as a Novel Antiviral Agent Against Porcine Epidemic Diarrhea Virus From a Cholesterol-Lowering Compound Library. [PDF]
Li Y +11 more
europepmc +1 more source
Inclisiran-induced LDL-cholesterol reduction with and without concomitant statin therapy: a real-world analysis. [PDF]
Seidel M +6 more
europepmc +1 more source
Effectiveness and safety of atorvastatin/ ezetimibe fixed-dose combination in hypercholesterolemia: a systematic review and network meta-analysis. [PDF]
Qian J, Zhang X, Li Q, Chen S.
europepmc +1 more source
Advanced therapy in familial hypercholesterolemia. [PDF]
Gao E, Brunham LR, Goldman RD.
europepmc +1 more source
PCSK9 inhibitors patterns of use in France from nationwide repeated cross-sectional and cohort studies. [PDF]
Singier A +5 more
europepmc +1 more source
Familial Hypercholesterolemia. [PDF]
Iatan I, Genest J.
europepmc +1 more source
Association Between PCSK9 Inhibitor Use and Risk of Age-Related Macular Degeneration. [PDF]
Tsai CY +7 more
europepmc +1 more source

